Buy Tirzepatide — Research-Grade Dual Agonist (Janoshik Tested)

Tirzepatide is a 39-amino-acid synthetic peptide engineered to engage both the GLP-1 and GIP receptors with balanced potency. A C20 fatty diacid moiety enables high-affinity albumin binding, supporting the long half-life that has made tirzepatide the gold-standard dual incretin in preclinical work.

Laboratory teams typically use tirzepatide as a benchmark against semaglutide (GLP-1 mono-agonist) and retatrutide (triple agonist) to study receptor crosstalk, β-cell signalling, lipid metabolism and hypothalamic appetite circuitry. Its long pharmacokinetic profile suits chronic-exposure rodent models without daily dosing.

Every Regena tirzepatide batch is tested by an independent European peptide laboratory — most commonly Janoshik Analytical — before any vial is released. The COA reports HPLC main-peak purity, peptide content by nitrogen, mass-spectrometry identity confirmation and a moisture figure by Karl Fischer.

Buyers can download the per-batch report from the Regena lab reports page, cross-referenced by the batch number printed on the vial cap. There is no aggregated, marketing-only COA — every report ties to a real, traceable production lot.

Lyophilised tirzepatide ships under inert atmosphere as a sterile white powder. Hold the unopened vial at 2–8 °C; for kits that will not be reconstituted within 8 weeks, transfer to −20 °C. Reconstitute with bacteriostatic water containing 0.9% benzyl alcohol — this gives reliable in-use stability for 28 days under refrigeration.

Most research protocols favour a 5 mg/ml or 10 mg/ml stock concentration for accurate microlitre dispensing. Avoid vigorous shaking — invert or swirl until clear. Aliquot before any freeze to minimise freeze–thaw cycles, which remain the single largest source of measurable potency loss in long-acting incretin analogues.

Regena dispatches tirzepatide from the Costa del Sol with same- or next-day delivery across Marbella, Málaga, Fuengirola, Estepona and wider Andalucía. National Spanish coverage is typically 24–48 hours via tracked courier. Cross-border EU shipping to Germany, France, Italy, Portugal, the Netherlands, Belgium and Scandinavia is handled by DHL Express with end-to-end tracking.

Every EU shipment carries the matching batch COA and a research-use customs declaration so the parcel clears border handling without delay. The Marbella consultations team can confirm import status for any specific EU country before an order is placed.

UK research clients order through the same Regena catalogue. Tracked dispatch from the European hub typically lands in 2–4 working days; DHL Express options are available for laboratories that need faster handover. Brexit-era VAT and customs handling are quoted transparently at checkout — no surprise import charges on delivery.

All UK orders ship with the same independent Janoshik COA used for EU clients. Additional paperwork (MSDS, certificate of origin, certificate of conformance) is supplied on request before dispatch.

US-based research clients receive tirzepatide via discreet, fully tracked international dispatch. Vials ship in temperature-buffered packaging to maintain cold chain across longer transit windows. The accompanying COA is identical to the document supplied to European laboratories.

US buyers should confirm institutional research-purchasing policy before ordering. Material is supplied strictly for research use and is not approved for human consumption in any jurisdiction.

Semaglutide engages GLP-1 alone; tirzepatide adds GIP receptor activity; retatrutide adds a third arm via glucagon receptor agonism. In preclinical models tirzepatide typically outperforms semaglutide on lipid metabolism and insulin sensitivity endpoints, while retatrutide tends to push energy-expenditure measurements higher again.

Laboratories building comparative panels often stock all three from Regena to keep batch documentation, dispatch logistics and packaging consistent across the panel. See the retatrutide-vs-tirzepatide comparison page for a deeper side-by-side.

Any honest tirzepatide supplier publishes the per-batch third-party COA, names the testing laboratory, and prints the batch number on the vial. Reject suppliers that recycle a single static COA across every batch, refuse to identify their analytical partner, or quote prices below the realistic cost of independent HPLC and MS testing — those are leading indicators of unverified or relabelled product.

Regena's consultations team walks new buyers through the COA, reconstitution maths and storage plan before any order is dispatched. Quality is the product.